We are live on
!
Find out more
Biogen
BIIB
BIIB
916 hedge funds and large institutions have $25.1B invested in Biogen in 2024 Q3 according to their latest regulatory filings, with 99 funds opening new positions, 270 increasing their positions, 378 reducing their positions, and 118 closing their positions.
New
Increased
Maintained
Reduced
Closed
0.51% more ownership
Funds ownership: 88.6% → 89.11% (+0.51%)
3% less funds holding
Funds holding: 943 → 916 (-27)
16% less first-time investments, than exits
New positions opened: 99 | Existing positions closed: 118
16% less capital invested
Capital invested by funds: $29.9B → $25.1B (-$4.82B)
24% less call options, than puts
Call options by funds: $214M | Put options by funds: $282M
29% less repeat investments, than reductions
Existing positions increased: 270 | Existing positions reduced: 378
33% less funds holding in top 10
Funds holding in top 10: 12 → 8 (-4)
Holders
916
Holders Change
-27
Holders Change %
-2.86%
% of All Funds
13.15%
Holding in Top 10
8
Holding in Top 10 Change
-4
Holding in Top 10 Change %
-33.33%
% of All Funds
0.11%
New
99
Increased
270
Reduced
378
Closed
118
Calls
$214M
Puts
$282M
Net Calls
-$67.3M
Net Calls Change
-$32.9M
Top Buyers
| 1 |
BlackRock
New York
|
+$169M |
| 2 |
Man Group
London,
United Kingdom
|
+$167M |
| 3 |
JP Morgan Chase
New York
|
+$113M |
| 4 |
Barclays
London,
United Kingdom
|
+$99.1M |
| 5 |
Two Sigma Investments
New York
|
+$91.2M |
